United States
Hide

Weight-loss drug Belviq may carry cancer risk, FDA warns

Breaking News EmailsGet breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.SUBSCRIBEJan. 14, 2020, 10:13 PM UTCBy Erika EdwardsFederal regulators are alerting the public that the prescription weight-loss drug Belviq may be associated with an increased risk of cancer, though it's unclear how big of a risk that might be.The Food and Drug Administration published the alert Tuesday afternoon, saying that a clinical trial assessing the medication's safety showed a "possible increased risk of cancer." Belviq is also known in its generic form as lorcaserin.Let our news meet your inbox. The news and stories that matters, delivered weekday mornings.Sign UpThis site is protected by recaptcha Privac ...
Top
Bottom